Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development

Although metabolic reprogramming is a recognized hallmark of cancer, the specific metabolic pathways driving hepatocellular carcinoma (HCC) development remain incompletely understood. Through metabolomic profiling of human HCC specimens, we reveal that amino acids and their analogues are the most profoundly dysregulated metabolites, with glutamine being notably depleted within the tumor microenvironment. Despite its perception as a generic nutrient, we demonstrate that dietary glutamine supplementation promotes the malignant transformation of tumor progenitors and accelerates proliferation in oncogene‐driven murine models, ultimately compromising overall survival. Metabolomic and 13 C‐isotope tracing analyses indicate that glutamine is preferentially channeled into de novo sphingomyelin (SM) synthesis. Both genetic and pharmacological interventions establish SM as the primary downstream effector mediating glutamine's pro‐tumorigenic effects. Mechanistically, SM accumulation promotes lipid raft formation, which subsequently activates TGF‐β signaling to induce epithelial–mesenchymal transition. This cascade compromises the epithelial integrity of preneoplastic hepatocytes, thereby driving malignant transformation and fueling tumor progression. Collectively, these findings provide a mechanistic rationale cautioning against glutamine supplementation in high‐risk populations and highlight potential novel metabolic vulnerabilities for the prevention and treatment of HCC.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2026-11-18
DOI
https://doi.org/10.1002/advs.78828
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development

Yuezheng Zhang, Yutao He, Bangya Peng, Yonglong Wei et al.
4 links
Advanced Science
Cancer, Lipids, and Metabolism
article

Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development

Yuezheng Zhang, Yutao He, Bangya Peng, Yonglong Wei, Lin Wang, Yiwen Zhang, Jiashun Xu, Jian Zhao, Huiling Zhu, Yue Sun, Z X Shi, Chang Shen, Xianjiao Mao, Tao Zhong, Haocheng Tang, Ming Gong, Qin Huang, Zhihong Tu, Chen Zhang, Weiran Liao, Chen Zhao, Peng Yang
article en

Abstract

Although metabolic reprogramming is a recognized hallmark of cancer, the specific metabolic pathways driving hepatocellular carcinoma (HCC) development remain incompletely understood. Through metabolomic profiling of human HCC specimens, we reveal that amino acids and their analogues are the most profoundly dysregulated metabolites, with glutamine being notably depleted within the tumor microenvironment. Despite its perception as a generic nutrient, we demonstrate that dietary glutamine supplementation promotes the malignant transformation of tumor progenitors and accelerates proliferation in oncogene‐driven murine models, ultimately compromising overall survival. Metabolomic and 13 C‐isotope tracing analyses indicate that glutamine is preferentially channeled into de novo sphingomyelin (SM) synthesis. Both genetic and pharmacological interventions establish SM as the primary downstream effector mediating glutamine's pro‐tumorigenic effects. Mechanistically, SM accumulation promotes lipid raft formation, which subsequently activates TGF‐β signaling to induce epithelial–mesenchymal transition. This cascade compromises the epithelial integrity of preneoplastic hepatocytes, thereby driving malignant transformation and fueling tumor progression. Collectively, these findings provide a mechanistic rationale cautioning against glutamine supplementation in high‐risk populations and highlight potential novel metabolic vulnerabilities for the prevention and treatment of HCC.

Advanced Science
Yunnan University (CN), Kunming Medical University (CN)
National Natural Science Foundation of China, Kunming Medical University, Yunnan University, Yunnan Provincial Science and Technology Department
Good health and well-being
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon